Skip to content

Latest commit

Β 

History

History
81 lines (61 loc) Β· 2.53 KB

File metadata and controls

81 lines (61 loc) Β· 2.53 KB

A Large-Scale Benchmark for Source-Free Test-Time Adaptation in Medical Image Segmentation

GitHub Leaderboard arXiv License

MedSeg-TTA is a benchmark for test-time adaptation in medical image segmentation. This repository centers on the public leaderboard, the benchmark figures behind it, and the currently available local method implementations organized by paradigm.

Leaderboard

πŸ‘‰ Click here to explore the full leaderboard in detail.

Benchmark Overview

The benchmark unifies medical TTA evaluation around a shared surface that connects source-target dataset pairs, paradigm-level comparisons, and local method code roots.

Framework

Dataset Coverage

MedSeg-TTA covers seven modalities and multiple cross-domain source-target pairs spanning MRI, CT, US, PATH, DER, OCT, and CXR.

Dataset Coverage

Repository Layout

MedSeg-TTA/
β”œβ”€β”€ medseg_tta/
β”œβ”€β”€ site/
β”œβ”€β”€ feature_level_alignment/
β”‚   β”œβ”€β”€ GraTa/
β”‚   β”œβ”€β”€ DANN/
β”‚   β”œβ”€β”€ UDA-MIMA/
β”‚   └── Testfit/
β”œβ”€β”€ input_level_transformation/
β”‚   β”œβ”€β”€ SFDA-FSM/
β”‚   β”œβ”€β”€ DLTTA/
β”‚   β”œβ”€β”€ AIF-SFDA/
β”‚   β”œβ”€β”€ STDR/
β”‚   └── RSA/
β”œβ”€β”€ output_level_regularization/
β”‚   β”œβ”€β”€ DG-TTA/
β”‚   β”œβ”€β”€ SaTTCA/
β”‚   β”œβ”€β”€ UPL-SFDA/
β”‚   └── tent/
β”œβ”€β”€ prior_estimation/
β”‚   β”œβ”€β”€ ExploringTTA/
β”‚   β”œβ”€β”€ AdaMI/
β”‚   β”œβ”€β”€ PASS/
β”‚   └── ProSFDA/
└── ASSETS.md

Assets and Licensing

Dataset provenance, third-party code sources, redistribution notes, and license details are documented in ASSETS.md.

Citation

If you find this project useful, please cite:

@article{anonymous2025medsegtta,
  title   = {A Large Scale Benchmark for Test Time Adaptation Methods in Medical Image Segmentation},
  author  = {Anonymous Authors},
  journal = {Anonymous preprint},
  year    = {2025}
}

License

This project is released under the MIT License. See LICENSE for details.